Sarepta Therapeutics, Inc.

SRPT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,103,010$428,430$966,777$2,115,869
Short-Term Investments$251,782$1,247,820$1,022,597$0
Receivables$649,728$436,975$261,600$172,745
Inventory$749,960$322,859$203,968$186,212
Other Curr. Assets$318,983$143,247$102,919$129,273
Total Curr. Assets$3,073,463$2,579,331$2,557,861$2,604,099
Property Plant & Equip (Net)$488,646$357,106$244,991$236,687
Goodwill$0$0$0$0
Intangibles$26,887$29,620$7,578$14,239
Long-Term Investments$136,873$6,527$31,321$34,892
Tax Assets$0$0$0$0
Other NC Assets$237,304$291,992$286,615$258,057
Total NC Assets$889,710$685,245$570,505$543,875
Other Assets$0$0$0$0
Total Assets$3,963,173$3,264,576$3,128,366$3,147,974
Liabilities
Payables$214,442$164,918$95,875$76,741
Short-Term Debt$13,473$123,328$15,489$15,051
Tax Payable$17,391$13,766$12,521$216
Deferred Revenue$130,256$50,416$89,244$89,244
Other Curr. Liab.$356,122$301,231$406,475$271,481
Total Curr. Liab.$731,684$653,659$619,604$452,733
LT Debt$1,329,597$1,273,480$1,601,870$1,138,388
Deferred Rev, NC$325,000$437,000$485,000$574,244
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$49,150$41,100$36,942$54,600
Total NC Liab.$1,703,747$1,751,580$2,123,812$1,767,232
Other Liabilities$0$0$0$0
Cap. Leases$205,946$158,810$73,067$56,563
Total Liabilities$2,435,431$2,405,239$2,743,416$2,219,965
Equity
Pref Stock$0$0$0$0
Common Stock$10$9$9$9
Retained Earnings-$4,210,974-$4,446,213-$3,910,236-$3,206,748
AOCI-$218$918-$1,664-$20
Other Equity$5,738,924$5,304,623$4,296,841$4,134,768
Total Equity$1,527,742$859,337$384,950$928,009
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,963,173$3,264,576$3,128,366$3,147,974
Net Debt$240,060$968,378$650,582-$962,430